EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today reported second quarter 2023 financial results and provided a corporate update. “Miromatrix remains on pace…Read More
Miromatrix Medical Inc Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
